Research ArticleCellular and Molecular
Dopamine Receptor D1 Is Exempt from Transforming Growth Factor β-Mediated Antifibrotic G Protein-Coupled Receptor Landscape Tampering in Lung Fibroblasts
Ashley Y. Gao, Ana M. Diaz Espinosa, Ba Bao N. Nguyen, Patrick A. Link, Jeffrey Meridew, Dakota L. Jones, Daniel F. Gibbard, Daniel J. Tschumperlin and Andrew J. Haak
Journal of Pharmacology and Experimental Therapeutics September 2023, 386 (3) 277-287; DOI: https://doi.org/10.1124/jpet.122.001442
Ashley Y. Gao
Departments of Physiology and Biomedical Engineering (A.M.D.E., P.A.L., J.M., D.L.J., D.J.T., A.J.H.), Ophthalmology (A.Y.G.), and Molecular Pharmacology and Experimental Therapeutics (B.B.N.N., D.F.G., A.J.H.), Mayo Clinic, Rochester, Minnesota
Ana M. Diaz Espinosa
Departments of Physiology and Biomedical Engineering (A.M.D.E., P.A.L., J.M., D.L.J., D.J.T., A.J.H.), Ophthalmology (A.Y.G.), and Molecular Pharmacology and Experimental Therapeutics (B.B.N.N., D.F.G., A.J.H.), Mayo Clinic, Rochester, Minnesota
Ba Bao N. Nguyen
Departments of Physiology and Biomedical Engineering (A.M.D.E., P.A.L., J.M., D.L.J., D.J.T., A.J.H.), Ophthalmology (A.Y.G.), and Molecular Pharmacology and Experimental Therapeutics (B.B.N.N., D.F.G., A.J.H.), Mayo Clinic, Rochester, Minnesota
Patrick A. Link
Departments of Physiology and Biomedical Engineering (A.M.D.E., P.A.L., J.M., D.L.J., D.J.T., A.J.H.), Ophthalmology (A.Y.G.), and Molecular Pharmacology and Experimental Therapeutics (B.B.N.N., D.F.G., A.J.H.), Mayo Clinic, Rochester, Minnesota
Jeffrey Meridew
Departments of Physiology and Biomedical Engineering (A.M.D.E., P.A.L., J.M., D.L.J., D.J.T., A.J.H.), Ophthalmology (A.Y.G.), and Molecular Pharmacology and Experimental Therapeutics (B.B.N.N., D.F.G., A.J.H.), Mayo Clinic, Rochester, Minnesota
Dakota L. Jones
Departments of Physiology and Biomedical Engineering (A.M.D.E., P.A.L., J.M., D.L.J., D.J.T., A.J.H.), Ophthalmology (A.Y.G.), and Molecular Pharmacology and Experimental Therapeutics (B.B.N.N., D.F.G., A.J.H.), Mayo Clinic, Rochester, Minnesota
Daniel F. Gibbard
Departments of Physiology and Biomedical Engineering (A.M.D.E., P.A.L., J.M., D.L.J., D.J.T., A.J.H.), Ophthalmology (A.Y.G.), and Molecular Pharmacology and Experimental Therapeutics (B.B.N.N., D.F.G., A.J.H.), Mayo Clinic, Rochester, Minnesota
Daniel J. Tschumperlin
Departments of Physiology and Biomedical Engineering (A.M.D.E., P.A.L., J.M., D.L.J., D.J.T., A.J.H.), Ophthalmology (A.Y.G.), and Molecular Pharmacology and Experimental Therapeutics (B.B.N.N., D.F.G., A.J.H.), Mayo Clinic, Rochester, Minnesota
Andrew J. Haak
Departments of Physiology and Biomedical Engineering (A.M.D.E., P.A.L., J.M., D.L.J., D.J.T., A.J.H.), Ophthalmology (A.Y.G.), and Molecular Pharmacology and Experimental Therapeutics (B.B.N.N., D.F.G., A.J.H.), Mayo Clinic, Rochester, Minnesota
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCellular and Molecular
Antifibrotic DRD1 Escapes TGF-β–Mediated Repression
Ashley Y. Gao, Ana M. Diaz Espinosa, Ba Bao N. Nguyen, Patrick A. Link, Jeffrey Meridew, Dakota L. Jones, Daniel F. Gibbard, Daniel J. Tschumperlin and Andrew J. Haak
Journal of Pharmacology and Experimental Therapeutics September 1, 2023, 386 (3) 277-287; DOI: https://doi.org/10.1124/jpet.122.001442
Research ArticleCellular and Molecular
Antifibrotic DRD1 Escapes TGF-β–Mediated Repression
Ashley Y. Gao, Ana M. Diaz Espinosa, Ba Bao N. Nguyen, Patrick A. Link, Jeffrey Meridew, Dakota L. Jones, Daniel F. Gibbard, Daniel J. Tschumperlin and Andrew J. Haak
Journal of Pharmacology and Experimental Therapeutics September 1, 2023, 386 (3) 277-287; DOI: https://doi.org/10.1124/jpet.122.001442
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement